In the first quarter of 2024, the Greater Boston lab market continued to reflect trends from the previous year, with caution prevailing among companies amidst ongoing economic uncertainty, according to Boston Metro Life Science Figures Q1 2024 from CBRE. This cautious approach has led to an uptick in lease renewals and an increase in available sublease space. Private companies facing selective venture capital funding are prioritizing cost efficiency, favoring second-generation spaces and spec labs to minimize initial capital outlay. 

While the Greater Boston Metro experienced a surge in industrial demand in 2021 and 2022, driven by pandemic-induced e-commerce activity, the market has since softened as demand levels stabilized. The quarter saw a net absorption of -1,935,831 square feet, primarily due to moderated demand for new spaces and a preference for lease renewals. This shift reflects the market’s adjustment to a more balanced state after the previous surge in demand.